Porphyromonas gingivalis antagonises Campylobacter rectus induced cytokine production by human monocytes

Cytokine

Volumn 39, Issue 2, 2007, Pages 147-156

  Bostanci, N ^a   Allaker, R P ^a   Belibasakis, G N ^a   Rangarajan, M ^a   Curtis, M A ^a   Hughes, F J ^a   McKay, I J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Campylobacter rectus; Cytokines; Interleukin 1; Interleukin 6; Interleukin 8; Lipopolysaccharide; Periodontal disease; Porphyromonas gingivalis

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE;

ARTICLE; CAMPYLOBACTER RECTUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLAMMATION; MONOCYTE; NONHUMAN; PATHOGENESIS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; SUPERNATANT;

CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER RECTUS; CELLS, CULTURED; CYTOKINES; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; MONOCYTES; PORPHYROMONAS GINGIVALIS;

BACTERIA (MICROORGANISMS); CAMPYLOBACTER RECTUS; PORPHYROMONAS GINGIVALIS;

EID: 34848890265     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.07.002     Document Type: Article

References (62)

1. Kazor C.E., Mitchell P.M., Lee A.M., Stokes L.N., Loesche W.J., Dewhirst F.E., et al. Diversity of bacterial populations on the tongue dorsa of patients with halitosis and healthy patients. J Clin Microbiol 41 (2003) 558-563
2. Aas J.A., Paster B.J., Stokes L.N., Olsen I., and Dewhirst F.E. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 43 (2005) 5721-5732
3. Paster B.J., Boches S.K., Galvin J.L., Ericson R.E., Lau C.N., Levanos V.A., et al. Bacterial diversity in human subgingival plaque. J Bacteriol 183 (2001) 3770-3783
4. Socransky S.S., Haffajee A.D., Cugini M.A., Smith C., and Kent Jr. R.L. Microbial complexes in subgingival plaque. J Clin Periodontol 25 (1998) 134-144
5. Lakshmyya K.N., Sathishkumar S., Bakthavatchalu V., Matthews C., Dawson D., Steffen M., et al. Polymicrobial periodontal disease: a rat model of polymicrobial infection, immunity, and alveolar bone resorption. Infect Immun (2007)
6. Bodet C., Chandad F., and Grenier D. Inflammatory responses of a macrophage/epithelial cell co-culture model to mono and mixed infections with Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia. Microbes Infect 8 (2006) 27-35
7. Holt S.C., Kesavalu L., Walker S., and Genco C.A. Virulence factors of Porphyromonas gingivalis. Periodontol 2000 20 (1999) 168-238
8. Slots J., and Ting M. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment. Periodontol 2000 20 (1999) 82-121
9. Albandar J.M., Brown L.M., and Loe H. Putative periodontal pathogens in subgingival plaque of young adults with and without early-onset periodontitis. J Periodontol 68 (1997) 973-981
10. Grossi S.G., Zambon J.J., Ho A.W., Koch G., Dunford R.G., Machtei E.E., et al. Assessment of risk for periodontal disease. I. Risk indicators of attachment loss. J Periodontol. 65 (1994) 260-267
11. Tanabe S., Hinode D., Yokoyama M., Fukui M., Nakamura R., Yoshioka M., et al. Helicobacter pylori and Campylobacter rectus share a common antigen. Oral Microbiol Immunol 18 (2003) 79-87
12. Moore W.E., Holdeman L.V., Cato E.P., Smibert R.M., Burmeister J.A., and Ranney R.R. Bacteriology of moderate (chronic) periodontitis in mature adult humans. Infect Immun 42 (1983) 510-515
13. Macuch P.J., and Tanner A.C. Campylobacter species in health, gingivitis, and periodontitis. J Dent Res 79 (2000) 785-792
14. Ihara H., Miura T., Kato T., Ishihara K., Nakagawa T., Yamada S., et al. Detection of Campylobacter rectus in periodontitis sites by monoclonal antibodies. J Periodontal Res 38 (2003) 64-72
15. Haffajee A.D., Socransky S.S., Dzink J.L., Taubman M.A., Ebersole J.L., and Smith D.J. Clinical, microbiological and immunological features of subjects with destructive periodontal diseases. J Clin Periodontol 15 (1988) 240-246
16. Tanner A., Maiden M.F., Macuch P.J., Murray L.L., and Kent Jr. R.L. Microbiota of health, gingivitis, and initial periodontitis. J Clin Periodontol 25 (1998) 85-98
17. Haffajee A.D., Dzink J.L., and Socransky S.S. Effect of modified Widman flap surgery and systemic tetracycline on the subgingival microbiota of periodontal lesions. J Clin Periodontol 15 (1988) 255-262
18. Page R.C., and Kornman K.S. The pathogenesis of human periodontitis: an introduction. Periodontol 2000 14 (1997) 9-11
19. Ishikawa I., Nakashima K., Koseki T., Nagasawa T., Watanabe H., Arakawa S., et al. Induction of the immune response to periodontopathic bacteria and its role in the pathogenesis of periodontitis. Periodontol 2000 14 (1997) 79-111
20. Schenkein H.A. Host responses in maintaining periodontal health and determining periodontal disease. Periodontol 2000 40 (2006) 77-93
21. Gemmell E., Marshall R.I., and Seymour G.J. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol 2000 14 (1997) 112-143
22. Oido-Mori M., Rezzonico R., Wang P.L., Kowashi Y., Dayer J.M., Baehni P.C., et al. Porphyromonas gingivalis gingipain-R enhances interleukin-8 but decreases gamma interferon-inducible protein 10 production by human gingival fibroblasts in response to T-cell contact. Infect Immun 69 (2001) 4493-4501
23. Taylor J.J., Preshaw P.M., and Donaldson P.T. Cytokine gene polymorphism and immunoregulation in periodontal disease. Periodontol 2000 35 (2004) 158-182
24. Landi L., Amar S., Polins A.S., and Van Dyke T.E. Host mechanisms in the pathogenesis of periodontal disease. Curr Opin Periodontol 4 (1997) 3-10
25. Okada H., and Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 9 (1998) 248-266
26. Bascones A., Noronha S., Gomez M., Mota P., Gonzalez Moles M.A., and Dorrego M.V. Tissue destruction in periodontitis: bacteria or cytokines fault?. Quintessence Int 36 (2005) 299-306
27. Dixon D.R., Bainbridge B.W., and Darveau R.P. Modulation of the innate immune response within the periodontium. Periodontol 2000 35 (2004) 53-74
28. Kornman K.S., Page R.C., and Tonetti M.S. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 14 (1997) 33-53
29. Mathur A., and Michalowicz B.S. Cell-mediated immune system regulation in periodontal diseases. Crit Rev Oral Biol Med 8 (1997) 76-89
30. Zappa U., Reinking-Zappa M., Graf H., and Espeland M. Cell populations and episodic periodontal attachment loss in humans. J Clin Periodontol 18 (1991) 508-515
31. Schlegel Gomez R., Langer P., Pelka M., von den Driesch P., Johannessen A.C., and Simon Jr. M. Variational expression of functionally different macrophage markers (27E10, 25F9, RM3/1) in normal gingiva and inflammatory periodontal disease. J Clin Periodontol 22 (1995) 341-346
32. Amano A. Molecular interaction of Porphyromonas gingivalis with host cells: implication for the microbial pathogenesis of periodontal disease. J Periodontol 74 (2003) 90-96
33. Taubman M.A., Valverde P., Han X., and Kawai T. Immune response: the key to bone resorption in periodontal disease. J Periodontol 76 (2005) 2033-2041
34. Blix I.J., and Helgeland K. LPS from Actinobacillus actinomycetemcomitans and production of nitric oxide in murine macrophages J774. Eur J Oral Sci 106 (1998) 576-581
35. Shapira L., Soskolne W.A., Sela M.N., Offenbacher S., and Barak V. The secretion of PGE2, IL-1 beta, IL-6, and TNF alpha by adherent mononuclear cells from early onset periodontitis patients. J Periodontol 65 (1994) 139-146
36. Yoshimura A., Hara Y., Kaneko T., and Kato I. Secretion of IL-1 beta, TNF-alpha, IL-8 and IL-1ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria. J Periodontal Res 32 (1997) 279-286
37. Socransky S.S., Haffajee A.D., Ximenez-Fyvie L.A., Feres M., and Maqer D. Ecological considerations in the treatment of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Periodontol 1999;20 (2000) 341-362
38. Curtis M.A., Aduse-Opoku J., and Rangarajan M. Cysteine proteases of Porphyromonas gingivalis. Crit Rev Oral Biol Med 12 (2001) 192-216
39. Darveau R.P., Belton C.M., Reife R.A., and Lamont R.J. Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect Immun 66 (1998) 1660-1665
40. Bostanci N., Allaker R., Johansson U., Rangarajan M., Curtis M.A., Hughes F.J., et al. Interleukin-1alpha stimulation in monocytes by periodontal bacteria: antagonistic effects of Porphyromonas gingivalis. Oral Microbiol Immunol 22 (2007) 52-60
41. Darveau R.P., Pham T.T., Lemley K., Reife R.A., Bainbridge B.W., Coats S.R., et al. Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. Infect Immun 72 (2004) 5041-5051
42. Wang P.L., and Ohura K. Porphyromonas gingivalis lipopolysaccharide signaling in gingival fibroblasts-CD14 and toll-like receptors. Crit Rev Oral Biol Med 13 (2002) 132-142
43. Hirschfeld M., Weis J.J., Toshchakov V., Salkowski C.A., Cody M.J., Ward D.C., et al. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 69 (2001) 1477-1482
44. Yoshimura A., Kaneko T., Kato Y., Golenbock D.T., and Hara Y. Lipopolysaccharides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists for human toll-like receptor 4. Infect Immun 70 (2002) 218-225
45. Coats S.R., Reife R.A., Bainbridge B.W., Pham T.T., and Darveau R.P. Porphyromonas gingivalis lipopolysaccharide antagonizes Escherichia coli lipopolysaccharide at toll-like receptor 4 in human endothelial cells. Infect Immun 71 (2003) 6799-6807
46. Hajishengallis G., Martin M., Schifferle R.E., and Genco R.J. Counteracting interactions between lipopolysaccharide molecules with differential activation of toll-like receptors. Infect Immun 70 (2002) 6658-6664
47. Hafsi N., Voland P., Schwendy S., Rad R., Reindl W., Gerhard M., et al. Human dendritic cells respond to Helicobacter pylori, promoting NK cell and Th1-effector responses in vitro. J Immunol 173 (2004) 1249-1257
48. Darveau R.P., and Hancock R.E. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J Bacteriol 155 (1983) 831-838
49. Ziegler-Heitbrock H.W., Thiel E., Futterer A., Herzog V., Wirtz A., and Riethmuller G. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int J Cancer 41 (1988) 456-461
50. Tietze K., Dalpke A., Morath S., Mutters R., Heeg K., and Nonnenmacher C. Differences in innate immune responses upon stimulation with gram-positive and gram-negative bacteria. J Periodontal Res 41 (2006) 447-454
51. Neustock P., Brand J.M., Kruse A., and Kirchner H. Cytokine production of the human monocytic cell line Mono Mac 6 in comparison to mature monocytes in peripheral blood mononuclear cells. Immunobiology 188 (1993) 293-302
52. Shapira L., Champagne C., Van Dyke T.E., and Amar S. Strain-dependent activation of monocytes and inflammatory macrophages by lipopolysaccharide of Porphyromonas gingivalis. Infect Immun 66 (1998) 2736-2742
53. Sugawara S., Nemoto E., Tada H., Miyake K., Imamura T., and Takada H. Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide hyporesponsiveness. J Immunol 165 (2000) 411-418
54. Duncan L., Yoshioka M., Chandad F., and Grenier D. Loss of lipopolysaccharide receptor CD14 from the surface of human macrophage-like cells mediated by Porphyromonas gingivalis outer membrane vesicles. Microb Pathog 36 (2004) 319-325
55. Takii R., Kadowaki T., Baba A., Tsukuba T., and Yamamoto K. A functional virulence complex composed of gingipains, adhesins, and lipopolysaccharide shows high affinity to host cells and matrix proteins and escapes recognition by host immune systems. Infect Immun 73 (2005) 883-893
56. Raetz C.R. Biochemistry of endotoxins. Annu Rev Biochem 59 (1990) 129-170
57. Reife R.A., Coats S.R., Al-Qutub M., Dixon D.M., Braham P.A., Billharz R.J., et al. Porphyromonas gingivalis lipopolysaccharide lipid A heterogeneity: differential activities of tetra- and penta-acylated lipid A structures on E-selectin expression and TLR4 recognition. Cell Microbiol 8 (2006) 857-868
58. Golenbock D.T., Hampton R.Y., Qureshi N., Takayama K., and Raetz C.R. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem 266 (1991) 19490-19498
59. Chen C., Coats S.R., Bumgarner R.E., and Darveau R.P. Hierarchical gene expression profiles of HUVEC stimulated by different lipid A structures obtained from Porphyromonas gingivalis and Escherichia coli. Cell Microbiol 9 (2007) 1028-1038
60. Darveau R.P., Arbabi S., Garcia I., Bainbridge B., and Maier R.V. Porphyromonas gingivalis lipopolysaccharide is both agonist and antagonist for p38 mitogen-activated protein kinase activation. Infect Immun 70 (2002) 1867-1873
61. Hinode D., Yoshioka M., Tanabe S., Miki O., Masuda K., and Nakamura R. The GroEL-like protein from Campylobacter rectus: immunological characterization and interleukin-6 and -8 induction in human gingival fibroblast. FEMS Microbiol Lett 167 (1998) 1-6
62. Ogura N., Matsuda U., Tanaka F., Shibata Y., Takiguchi H., and Abiko Y. In vitro senescence enhances IL-6 production in human gingival fibroblasts induced by lipopolysaccharide from Campylobacter rectus. Mech Ageing Dev 87 (1996) 47-59